Senior Advisor - Statistics at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Ph.D. in Statistics OR Biostatistics with at least 3 years of experience in Clinical Research and Development
  • Proficient in statistical programming languages/software such as SAS, R, Spotfire, WinBUGs, etc
  • Interpersonal communication skills for effective customer consultation
  • Teamwork and leadership skills
  • Technical expertise and application with working knowledge of experimental design and statistical analysis
  • Self-management skills with a focus on results for timely and accurate completion of competing deliverables
  • Resource management skills
  • Creativity and innovation
  • Demonstrated problem solving ability and critical thinking

Responsibilities

  • Provide input on study protocol, design studies and write protocols for the conduct of each study
  • Be accountable for selecting statistical methods for data analysis, authoring the corresponding sections of the protocol and the statistical analysis plan, and conducting the actual analysis once a reporting database is created
  • Collaborate with data sciences in the planning and implementation of data quality assurance plans
  • Maintain currency with respect to statistical methodology, maintain proficiency in applying new and varied methods, and be competent in justifying methods selected
  • Perform peer-review of work products from other statistical colleagues
  • Influence team members regarding appropriate research methods
  • Collaborate with team members to write reports and communicate results
  • Assist with, or be responsible for, communicating study results via regulatory submissions, manuscripts, or oral presentations in group settings, as well as for communicating one-on-one with key customers and presenting at scientific meetings
  • Respond to regulatory queries and interact with regulators
  • Understand disease states, competitive landscapes, and regulatory environment in order to enhance the level of customer focus and collaboration and be seen as a strong scientific contributor
  • Perform work in full compliance with assigned curriculum(s) and follow applicable Corporate, Medical, local, and departmental policies, procedures, processes, and training
  • Introduce and apply innovative methodology and tools to solve critical problems
  • Merge scientific thinking and business knowledge to identify issues, evaluate options and implement solutions
  • Lead projects independently and work effectively across functions
  • Apply technical expertise to influence business decisions

Skills

Statistical Trial Design
Study Protocol Development
Statistical Analysis
Data Analysis Plans
SAS
R
Clinical Study Design
Peer Review
Data Quality Assurance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI